Publication Date:
2021
Short description:
First-line therapies in late-onset multiple sclerosis: An Italian registry study / Zanghì, A., Avolio, C., Amato, M.P., Filippi, M., Trojano, M., Patti, F., D'Amico, E.. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 28:(2021), pp. 4117-4123. [10.1111/ene.15006]
abstract:
The diagnosis of late-onset (age ≥50 years old) relapsing remitting multiple sclerosis (LORRMS) has been increasingly described in clinical practice, whereas data focusing on the specific therapeutic management of LORRMS are scarce. Our objective was to compare the effectiveness of injectable and oral first-line disease-modifying therapies (DMTs) in a cohort of LORRMS patients with time to first relapse, time to confirmed disability progression (CDP), and time to discontinuation.
Iris type:
1.1 Articolo in rivista
Keywords:
first choice; injectable disease-modifying therapies; late onset; multiple sclerosis; oral disease-modifying therapies
List of contributors:
Zanghì, Aurora; Avolio, Carlo; Amato, Maria Pia; Filippi, Massimo; Trojano, Maria; Patti, Francesco; D'Amico, Emanuele
Published in: